Citi lowered the firm’s price target on IFF (IFF) to $75 from $82 and keeps a Buy rating on the shares as part of a Q3 preview for the specialty chemicals group. The firm continues to see a challenging macro environment for the group with volumes underperforming across end markets.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IFF:
